# generate_tests\Test mAB\Mix-all.txt
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Trypsin - 25%
THTCPPCPAPELLGGPSVFLFPPKPK
TPEVTCVVVDVSHEDPEVK
NQVSLTCLVK
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Chymotrypsin - 25%
TISRDNSKNTL
VRGVIDVF
GGPSVF
RVVSVL
PSDIAVEW
KTTPPVL
DSDGSF
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - LysC - 25%
GPSVFPLAPSSK
PREEQYNSTYRVVSVLTVLHQDWLNGK
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Aspecific - 25%
QVQLVESGGGVVQPGRSLRL
ESGGGVVQPGRSLRLS
ESGGGVVQPGRSLRLSCAASGFSFSNY
GGGVVQPGRSLRLSCAASGFSFSNYGMHWVRQAP
SLRLSCAAS
SLRLSCAASGFSFSNYGMHWVRQAPGKGLEWVALIWY
ASGFSFSNYGMHW
GFSFSNYGMHWVR
GKGLEWVALIWYDGSNEDYTDSVKGRFTI
KGLEWVALIWY
VALIWYDGSNEDYTDS
IWYDGSNEDYTDSVKGR
DGSNEDYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAV
DSVKGRFTISR
GRFTISRDNSKNTLYL
SRDNSKNTLYLQMNSLRAEDTAVYY
LQMNSLRAEDTAVYYC
AEDTAVYYCARWGM
VIDVFDIWGQGTVV
FDIWGQGTVVTVSSASTKGP
GQGTVVTVSSASTKGPSVFPLAPS
VVTVSSASTKGPSVFPLAPSSK
VVTVSSASTKGPSVFPLAPSSKSTSGGTAALGC
VKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSS
KDYFPEPVTVSWNS
VTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSS
SGALTSGVHTFPAVLQSSGLYS
HTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNV
QSSGLYSLSSVVTVPSSSLGTQTYICN
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNT
LSSVVTVPSSSLGTQTYIC
VVTVPSSSLGTQTYICNVNHKPSNTKVDKR
VPSSSLGTQTY
SLGTQTYICNVNHKPSNTKVDKRVEP
CNVNHKPSNTKVDKRVEPKSCD
RVEPKSCDKTHTCPPCPAPELLGGPS
PKSCDKTHTCPPCPAPEL
DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRT
PKDTLMISRTP
KDTLMISRTPEVTCVVVDVSHEDPEVKFNW
SRTPEVTCVVVDVSHEDPEVKFNWY
RTPEVTCVVVDVSHEDPE
RTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTK
TPEVTCVVVDVSHEDPEVKFN
EDPEVKFNWYVDGVE
EVKFNWYVDGVEVHNAKTKPREEQY
VKFNWYVDGVEVHNAK
FNWYVDGV
YVDGVEVHNAKT
EVHNAKTKPR
YNSTYRVVSVLTVLHQDWLNGKEYKCKVSNK
NSTYRVVSVLTVLHQDWLNGKEYKCKV
VVSVLTVLHQDWLNGKEYKCKVSNK
VSVLTVLHQDWLNGKEYKCKV
LTVLHQDWLNGKEYKCKVSNKALPAPIEKTIS
TVLHQDWLNGKEYKCKVSNKALPAPI
HQDWLNGK
DWLNGKEYKCKVSNKALP
WLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLP
KCKVSNKALPAPIEKTISKAKGQPRE
KALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQ
EKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGF
SKAKGQPREPQVYTLPPSR
KGQPREPQVYTLPPSREEMTKNQVSLTC
REPQVYTLPP
QVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNG
EEMTKNQVSL
EEMTKNQVSLTCLVKGFYPSDIAVEWE
LTCLVKGFYPSDIAVEWESNGQPENNY
LVKGFYPSDIAVEWESN
ESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ
NNYKTTPP
DGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALH
GSFFLYSK
DKSRWQQGNVFSCSV
SRWQQGNVFSCSVMHEALHNH
QQGNVFSCSVMHEALHNHYTQKSLSLSP
GNVFSCSVMHEALHNHYTQK
CSVMHEALH
# Generated sample - 9568H|actoxumab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Alfalytic protease - 25%
FDIWGQGT
PELLGGPS
HEDPEV
LHQDWLNGKEYKCKV
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 25%
DIQMTQSPSSVSASVGDR
SGTASVVCLLNNFYPR
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 25%
SSPVTKSF
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 25%
SFNRGEC
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 25%
QMTQSPSSVSASVGDRVTI
SQGISSWLA
SSWLAWYQHKPGKAPKLLIYAASS
WYQHKPGKAPKLLIYAASSLQS
YQHKPGKAPKLLIYAASSLQSGVPSRF
PKLLIYAASSLQSG
LIYAASSLQSGVPSRFSGSGSGTDFTLTIS
YAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAT
LQSGVPSRFSGSGSGTDFTLTISSL
TDFTLTISSLQPEDFATYYCQQANSFPW
FTLTISSLQPEDFATYYCQQANSFPWTFGQGTKVEIKRT
TLTISSLQPEDFATYYCQQANSFPW
TLTISSLQPEDFATYYCQQANSFPWTFGQGTKVEIKRTVA
LTISSLQPEDFATYYCQQANSFPWTFGQGTKV
PEDFATYYCQQANSFPWTFG
TFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGT
QGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNN
PPSDEQLKSGTASVVCL
LKSGTASVVCLLNNFYPREAKVQWKVDNALQSGN
TASVVCLLN
TASVVCLLNNFYPREAKVQWKVDNALQSG
VVCLLNNFYPREAKVQWKVDNALQSGNSQ
LNNFYPREAKVQWKVDNALQSGNSQESVTEQ
PREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSST
KVDNALQSGNSQ
LQSGNSQESVTEQDSKDSTYSLSS
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVY
QESVTEQDSKDSTYSLSSTLTLSKADYEKHK
DSTYSLSSTLTLSKADYEKHKV
TYSLSSTLTLSKADYEKHKVYACEV
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
DYEKHKVYACE
HQGLSSPVT
QGLSSPVTKSFN
# Generated sample - 9568L|actoxumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 25%
FNRGEC
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Trypsin - 25%
NSLYLQMNSLR
GPSVFPLAPSSK
EEQYNSTYR
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Chymotrypsin - 25%
VQPGRSL
VSAITW
RAEDTAVY
PEPVTVSW
ISRTPEVTCVVVDVSHEDPEVKF
KCKVSNKAL
PSDIAVEW
ESNGQPENNY
TVDKSRW
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - LysC - 25%
GLEWVSAITWNSGHIDYADSVEGRFTISRDNAK
PREEQYNSTYRVVSVLTVLHQDWLNGK
GQPREPQVYTLPPSRDELTK
SLSLSPGK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Aspecific - 25%
EVQLVESGGGLVQPGRSLRLSCAAS
PGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAI
LSCAASGFTFDDYAMHWVRQAPGKGLEWVSA
CAASGFTFDDYAMH
AASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYAD
ASGFTFD
FTFDDYAMHWVR
DYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSV
SGHIDYADSVEGRFTISRDNAKNSLYLQMNSLR
GHIDYADSVEGRFTISR
SVEGRFTISRDNAKNSLYLQM
TISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSL
RDNAKNSLYLQ
DNAKNSLYLQMN
YCAKVSYLSTA
TASSLDYWGQGTLVTVS
GQGTLVTVSSASTKGPSVFPLA
TLVTVSSASTK
STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSW
TKGPSVFPLAPSSKSTSG
PSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHT
SKSTSGGTAALGCLVKDYFPEPV
EPVTVSWNSGALTSGVHTFPAVLQ
TVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPS
VSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLG
NSGALTSG
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSL
TSGVHTFPAVLQSSGLYSLS
VHTFPAVL
LQSSGLYSLSSVVTVPSSSLGTQTYICN
SSGLYSLSSVVTVPSSSLGTQTYIC
SGLYSLS
SVVTVPSSSLGTQTYICNVNHK
KPSNTKVD
SNTKVDKKVEPKSCDKTHTCPPCPAP
DKKVEPKSCDKTHTCPPCPAPELLGGPSVFLF
EPKSCDKTHTCPPCPAPE
SCDKTHTCPPCPAPELLGGP
KTHTCPPCPAPELLGGPSVF
PCPAPELLGGPSVFLFPPKPKDTLMI
APELLGGP
APELLGGPSVFLFPPKPKDTLMISRTPEVTCV
SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVK
LMISRTPEVTCVVVDVSHEDPEVKF
VTCVVVDVSHEDPEVKFN
VTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQ
VVVDVSHEDPEVKFNWYVDGVEVHNAKT
VDVSHEDPEVKFNWYVDGVEVHNAKTK
EDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVL
YVDGVEVHNAKTKPREEQYNST
AKTKPREEQ
YNSTYRVVSVLTVLHQDWLNGKEYKCK
STYRVVSVL
VLHQDWLNGKEYKCKV
HQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQ
PAPIEKTISKAKGQPREPQVYTLPPSRDELTK
APIEKTISKAKGQPREPQVYTLPPSRDELTK
PIEKTISKAKGQPREPQVYTL
PSRDELTKNQVSLTCLVKG
SRDELTKNQVSLTCLVKGFYPSDIAVE
CLVKGFYPSDIAVEWESNGQPENNY
CLVKGFYPSDIAVEWESNGQPENNYKTTPPVL
SDIAVEWESNGQPENNYKTTPP
DIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLT
EWESNGQ
WESNGQPENNYKTTPPVL
NGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVF
VLDSDGSFFLYSKLTVDKSRWQQGNV
VLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNH
LDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALH
FLYSKLTVDK
SKLTVDKSRWQQGNV
SKLTVDKSRWQQGNVFSCSVMHEALHNHY
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Alfalytic protease - 25%
PGKGLEWV
LYLQMNS
KDYFPEPV
HEDPEV
KFNWYV
KGQPREPQV
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 25%
NYLAWYQQKPGK
VYACEVTHQGLSSPVTK
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 25%
QSGVPSRF
QPEDVATY
KVDNAL
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 25%
SGTASVVCLLNNFYPREAK
SFNRGEC
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 25%
SQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGV
IRNYLAWYQQKPGKAPKLLIYAASTLQSG
KPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDF
APKLLIYAASTLQSGV
APKLLIYAASTLQSGVPSRFSGSGS
KLLIYAASTLQSGVP
LIYAASTLQSGVPSRFSGS
YAASTLQSGVPSR
QSGVPSRFSGSGSGTDFT
SGVPSRFS
SGVPSRFSGSGSG
GVPSRFSGSGSGTDF
EDVATYYC
ATYYCQRYNRAPYTF
ATYYCQRYNRAPYTFGQGTKVEIKRTVAAPSVFIF
YNRAPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQL
GTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLN
TKVEIKR
RTVAAPSVFIFPPSDEQLKSGTASVVCLLNNF
FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQ
DEQLKSGTASVVCLLNNFYP
FYPREAKVQWKVDNALQS
YPREAKVQ
PREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSST
VQWKVDNALQSGNSQESVTEQD
NALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYE
ALQSGNSQESVTEQDSKDSTYSLS
SGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
SKADYEKHKVYACEVTHQGLSSPVTK
SKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
KHKVYACEVTHQGLSSPVTKSFNRGE
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 25%
YYCQRYNRA
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Trypsin - 25%
QVQLLESGGGLVQPGGSLR
GLEWVSGISGSGSSTYYADSVK
NTLYLQMNSLR
AEDTAVYYCAR
GPSVFPLAPSSK
TPEVTCVVVAVSHEDPEVK
EEQYNSTYR
GFYPSDIAVEWESNGQPENNYK
SLSLSPGK
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Chymotrypsin - 25%
ESGGGL
TSGVHTF
TKNQVSL
PSDIAVEW
DSDGSF
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - LysC - 25%
GPSVFPLAPSSK
STSGGTAALGCLVK
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
SRWQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Aspecific - 25%
LESGGGLVQPGGSLRLSCAASGFTFSTAAMSWVRQ
GLVQPGGSLRLSCAASGFTFSTAAMSWVRQAPGKGLEW
SLRLSCAASGFTFSTAA
CAASGFTFSTAAMSWVRQAPGKGLEW
GFTFSTAAMSWVRQAPG
WVRQAPGKGLEWVSGISGSGSSTYYADSVKG
PGKGLEW
PGKGLEWVSGISGSGSSTYYADSVKGRFTISR
LEWVSGISGSGSSTYYADSVKGRFTISRDNS
WVSGISGSGSSTYYADSVKGRFT
GISGSGSSTYYADSVKGRFTISRDNSKNTLYLQMNSL
ISGSGSSTYYADS
TYYADSVK
YADSVKGRFTISRDNSKNTLYL
SVKGRFTISRDNSKNTLYLQMN
KGRFTISRDNSKNTLYLQMNSLRAED
TISRDNSKNTLYLQMNSLRAED
KNTLYLQMNSLRAEDTAVYYCARELSYLYSGYYF
RAEDTAVYYCARELSYLYSGYYFDYWGQGTLVTVSSA
DTAVYYCARELSYLYSGYYFDYWGQGTLVTVS
AVYYCARELSYLYSGY
RELSYLYSGYYFDYWGQG
SGYYFDYWGQGTL
VTVSSASTKG
VSSASTKGP
SSASTKGPSVFPLAP
APSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVH
PSSKSTSGGTAALGCLVKDYFPEPV
TSGGTAALGCLVKDYFPEP
ALGCLVKDYFPEPVTVSWNSG
CLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL
PEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
PVTVSWNSGALTSGVHTFPAVLQSSGLY
TVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVP
SWNSGALTSGVH
NSGALTSGVHTFPAVLQSSGLYSLSSVV
TFPAVLQSSGLYSLSSVVT
SSGLYSLSSVVTVPSSS
LYSLSSVVTVPSSSLGTQTYICNV
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK
QTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAP
NHKPSNTKVDKRVEPKSCDKTHTCPPCPA
DKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTL
PKSCDKTHTCPPCPAPELLGGPSVFLFPPKP
DKTHTCPPCPAPELLG
PELLGGPSVFLFPPKPKDTLMISRTPE
ELLGGPSVFLFPPKPKDTLMISRTPEVTC
KPKDTLMIS
KPKDTLMISRTPEVTCVVVAVSHEDPEVKFNWYVD
PKDTLMISRTPEVTCVVVAVSHEDPEVKFNWY
RTPEVTCVVVAVSHEDPEVKFNWYVDGVEVHNAKT
CVVVAVSHEDPEVKFNWYVDGVEVHNAKTKPREEQY
AVSHEDPEVKFNWYVDGVEVHNAKTKPREEQ
HEDPEVKFNWYVDGVEVHNAKTKPREE
PEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVL
VKFNWYVDGVEVHNA
FNWYVDGVEVHNA
REEQYNSTYRVVSVLTVLHQDWLN
EEQYNSTYRVVSVLTVLH
YNSTYRVVSVLTVLHQDWLNGK
NSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALAAPIEK
TYRVVSVLTVLHQDWLNGKEYKCKVSNKALAAPIEKT
VLTVLHQD
LTVLHQDWLNGKEYKCKVSNKALAAPIEKTIS
DWLNGKEYKCKVSNKALAAPIE
VSNKALAAPIEKTISKAKGQPREPQVYTLPPSR
EEMTKNQVSLTCLVKGFYPSDIAVEWESNGQ
NQVSLTCLVKGFYPSDIAVEWES
TCLVKGFYPSDIAVEWESNGQPENNYKTTPPV
KGFYPSDIAVEW
KGFYPSDIAVEWESNGQPENNYKTTPPVL
DIAVEWESNGQPENNYKTTPPVLDSDGSFFLY
NGQPENNYKTTPPVLDSDGSFFLYSKLT
QPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFS
VLDSDGSFFLYSKLTVDKS
GSFFLYSKLTVDKS
LYSKLTVDKSRWQQGNVFSCSVMHEALHN
DKSRWQQGNVFSCSVMH
KSRWQQGNVFSCSVMHEALHNHYTQK
RWQQGNVFS
HEALHNHYTQKSLSLS
# Generated sample - 10881H|abelacimab|Homo sapiens||H-GAMMA-1 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (236-345) [D3] + CH3 (346-450) [D4])|||||||452|452|||MW undefined|MW undefined| - Alfalytic protease - 25%
GYYFDYWGQGT
CPPCPA
PELLGGPS
LHQDWLNGKEYKCKV
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Trypsin - 25%
QSVLTQPPSASGTPGQR
NYNRPSGVPDR
SGTSASLAISGLQSEDEADYYCSAWDQR
QFDVVFGGGTK
AAPSVTLFPPSSEELQANK
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Chymotrypsin - 25%
PGTAPKL
SGSKSGTSASL
GGGTKL
QANKATL
SCQVTHEGSTVEKTVAPTECS
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - LysC - 25%
AAPSVTLFPPSSEELQANK
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Aspecific - 25%
PPSASGTP
PPSASGTPGQRVTISCS
SGTPGQRVTISCSGSSSNIGSNDVSWY
SSSNIGSNDVSWYQQLPGTAPKLLIYKNYNRPSGVPDRF
GSNDVSWYQQLPGTAPKLLIY
VSWYQQLPGTAPKLLIYKNY
SWYQQLPGTAPKLLIYKNYNRPSGVPDRFSGSKSGT
WYQQLPGTAP
YQQLPGTAPKLLIYKNYNRPSGVPDRFSGSKSGT
LPGTAPKLLIYKNYNRPSGVP
LPGTAPKLLIYKNYNRPSGVPDRFSGSKSGTSASLA
APKLLIYKNYN
LIYKNYNRPSGVPDRFSGSKSGTSA
DRFSGSKSGTSASLAISGLQSEDEA
RFSGSKSGTSASLA
SLAISGLQSEDEADYYCSAWDQR
AISGLQSEDE
AISGLQSEDEADYYCSAWDQRQFDVVFGGGTKLT
EDEADYYCSAWDQRQFDVVFGGGTKLTVLGQPKAAPS
QFDVVFGGGTKLTVLGQPKAAPSVTLFPPSSE
VVFGGGT
GGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLI
TKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLIS
KLTVLGQPKAAPS
QPKAAPSVTLFPPSSE
QPKAAPSVTLFPPSSEELQANKATLVCLIS
PKAAPSVTLFPPSSEELQANKA
LQANKATLVCLISDFYPGAV
TLVCLISDFYPGAV
LVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNN
FYPGAVTVAWKADSSPVKA
DSSPVKAGVETTTPSKQSNNKYAASSYLSL
PVKAGVETTTPSKQSNNKYAASSYLSLTPEQWK
GVETTTPSKQSNNKYAASSYL
TTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEG
PSKQSNN
YLSLTPEQWKSHRSYSCQVT
LSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT
SHRSYSCQVTHEG
# Generated sample - 10881L|abelacimab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Alfalytic protease - 25%
PKLLIYKNYNRPS
DFYPGA
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Trypsin - 25%
QVELVQSGAEVK
SISTAYLQWSSLK
ASDTAMYYCAR
STSGGTAALGCLVK
THTCPPCPAPELLGGPSVFLFPPKPK
GFYPSDIAVEWESNGQPENNYK
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Chymotrypsin - 25%
ICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPEL
KCKVSNKAL
KTTPPVL
DSDGSF
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - LysC - 25%
GLEWMGIIDPGDSRTRYSPSFQGQVTISADK
SISTAYLQWSSLK
ASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSSASTK
DTLMISRTPEVTCVVVDVSHEDPEVK
FNWYVDGVEVHNAK
GFYPSDIAVEWESNGQPENNYK
TTPPVLDSDGSFFLYSK
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Aspecific - 25%
LVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGK
QSGAEVKKPGESLKISCKGSGY
QSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGKGL
PGESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGI
SLKISCKGSGYSFTSYWIGWVR
CKGSGYSFTSYWIGWVRQAPGKGL
FTSYWIGWVRQAPGKGLEWMGIIDPGDSR
SYWIGWVRQAPGKGLEWMGIIDPGDSRTRY
WIGWVRQAPGKGLEWMGIIDPGDS
IGWVRQAPGKGLEWMGIIDPGDS
IGWVRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTIS
APGKGLEWMGIID
PSFQGQVTISADKSISTAYLQWSSLKASDT
QVTISADKSISTAYLQWSS
ISTAYLQWSSLKASDTAMYYCARGQLYGGTYMDG
YYCARGQLYG
CARGQLYGGTYMDGWGQGTLVTV
QLYGGTYMDGWGQGTLVTVSSASTKGPSVFPLAPSSKS
YMDGWGQGTLVTVSS
MDGWGQGTLVTVSSASTKGPSVFPLAPSSKST
DGWGQGTLVTVSSASTKG
QGTLVTVSSASTKG
FPLAPSSKSTSGGTAALGCLV
FPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNS
GGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
ALGCLVKDYFPEP
DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
TVSWNSGAL
TVSWNSGALTSGVHTFPAVLQSSGLY
SGALTSGVHTFPAVLQSSGLYSL
GVHTFPAVLQSSGLYSLSSVVTVPSSSL
VHTFPAVLQSSGLYS
HTFPAVLQSSGLYSL
HTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHK
AVLQSSGLYSLSSVVTVPSSSLG
LYSLSSVVTVPSSSLGTQTYICNVNHKPSNT
SLSSVVTVPSSSLGT
LSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
SVVTVPSSSLGTQTYICNVNHKPSNTKVDKK
SSLGTQTYICNVNHKPSNTKVD
QTYICNVNHKPSNTKVD
YICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGG
NHKPSNTKVD
PSNTKVDKKVE
TKVDKKVEPKSCDKTHTCPPC
TKVDKKVEPKSCDKTHTCPPCPAPELLG
CPAPELLGGPSVFLFPPKPKD
PELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVD
LGGPSVFLFPPKPKDTL
FPPKPKDTLMISRTPEVTCVVVD
LMISRTPEVT
VVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS
EVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQ
FNWYVDGVEVHNAKTKPREEQYNSTYRVVSV
AKTKPREEQYNSTYRVVSVLT
EQYNSTYRVVSVLTVLHQDWLNG
VLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQ
WLNGKEYKCKVSNKALPAPIE
NGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLP
YKCKVSNKALP
YKCKVSNKALPAPIEK
KVSNKALPAPIE
PAPIEKT
PIEKTISKAKGQPRE
ISKAKGQPREPQVYTLPPSRDELTKN
EPQVYTLPP
QVYTLPPSRDELTKNQV
LTKNQVSLTCLVKGFYPS
VSLTCLVKGFYPSDIAVEWESNGQPENNYKTTP
VKGFYPSDIAVEWESNG
AVEWESNGQPENNYKTTPPVLDSDGSF
AVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVD
EWESNGQPENNYKTTPPVLD
EWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSR
YKTTPPVLDSDGSFFLYSK
TPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSC
SKLTVDKSRWQQGNVFSCSV
NVFSCSV
FSCSVMHEALHNHY
MHEALHNHYTQKSLSLSPG
# Generated sample - 9788H|anetumab ravtansine|Homo sapiens||H-GAMMA-1 (VH (1-120) [D1] + CH1 (121-218) [D2] + CH2 (234-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Alfalytic protease - 25%
KFNWYV
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Trypsin - 25%
LMIYGVNNRPSGVSNR
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Chymotrypsin - 25%
GVNNRPSGVSNRF
GGGTKL
GQPKAAPSVTL
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - LysC - 25%
LMIYGVNNRPSGVSNRFSGSK
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Aspecific - 25%
IALTQPASVSGSPGQSITISCTGTSS
TQPASVSGSP
SPGQSITISCTGTSSDIGGYNSVSWYQQHP
SCTGTSSDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGV
CTGTSSDIGGYNSVSWYQQHPGKAPKL
SSDIGGYNSVSWYQQH
SDIGGYNSVSWYQQHPGK
YNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKSG
VSWYQQHPG
YQQHPGKAP
PKLMIYGVNNRPSGVSNR
NNRPSGVSNRFSG
NNRPSGVSNRFSGSKSGNTASLTISGLQAED
NRFSGSKSGNTASLTISGLQAEDEADYYCSSYDI
SKSGNTASLTISGLQ
NTASLTISGLQAEDEADYYCSSYDIESATPVFG
ISGLQAEDEADYYCSSYDIESATPVFG
LQAEDEADYYCSSYDIESATPVFGGGTKLTVL
DYYCSSYDIESATPVFGGGTKLTVLGQPKAAPSV
IESATPVFG
SATPVFGGGT
FGGGTKLTVLGQPKAAPSVTLFPPSSEE
KLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDF
LTVLGQPKAAPSVTLFPPSSEE
KATLVCLISDFYPGAVTVAW
DFYPGAVTVAWKGDSSPVKAGVETTTPSK
YPGAVTVAWKGD
YPGAVTVAWKGDSSPVKAGVETTTP
YPGAVTVAWKGDSSPVKAGVETTTPSKQSNNKYAASS
PGAVTVAWKGD
GAVTVAWKGD
TVAWKGDSSPVKAG
AWKGDSSPVKAGVETTTPSKQS
AGVETTTPSKQSNNK
AGVETTTPSKQSNNKYAASSYLSLTPEQ
ETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSC
WKSHRSYSCQVTHEGSTVEKTVAP
# Generated sample - 9788L|anetumab ravtansine|Homo sapiens||L-LAMBDA (V-LAMBDA (3-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Alfalytic protease - 25%
PKLMIYGV
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Trypsin - 25%
STSESTAALGCLVK
TPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAK
EPQVYTLPPSR
WQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Chymotrypsin - 25%
TEDTSTDTAY
PEPVTVSW
TSGVHTF
SSVVTVPSSNF
PPKPKDTL
RVVSVL
KCKVSNKGL
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - LysC - 25%
PGASVK
GLEWMGGFDPQDGETIYAQK
FQGRVTMTEDTSTDTAYMELSSLK
SEDTAVYYCATGSSSSWFDPWGQGTLVTVSSASTK
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Aspecific - 25%
EVKKPGASVKV
VKVSCKVSG
CKVSGYTLSDLSIHWVRQAPG
SDLSIHWVRQ
DLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQG
WVRQAPGKGLEWMGGFD
APGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTS
LEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDT
GGFDPQDGETIYAQKF
DPQDGETIYAQK
ELSSLKSEDTAVYYCATGSSSSWFDPWGQG
KSEDTAVYYCATGSSSS
ATGSSSSWFDPWGQGT
GQGTLVTVSSASTKG
GTLVTVSSASTKGPSVFPLAPCSRSTSE
SSASTKGPSVFPLAPCS
TKGPSVFPLAPCSRSTSESTAAL
TKGPSVFPLAPCSRSTSESTAALGC
TKGPSVFPLAPCSRSTSESTAALGCLVKDYF
CSRSTSESTAALGCLVKDYFPEPVTVSW
CSRSTSESTAALGCLVKDYFPEPVTVSWNSGALT
STSESTAALGCLVKDYFPEPVTVSWNSGAL
KDYFPEPVTVSWNSGA
YFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVV
PVTVSWN
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFG
GALTSGVHT
TSGVHTFPAVLQSSGLY
TSGVHTFPAVLQSSGLYSLSS
GLYSLSSVVTVPSSNFGTQTYT
SVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERK
VVTVPSSNFGTQTYTCNVDHKPSNTK
TVPSSNFGTQ
SNFGTQTYTCNVDHKPSNTKVDK
SNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPC
QTYTCNVDHKP
TCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAG
VDHKPSNT
ERKCCVECPPCPAP
PPCPAPPVAGPSVFLFP
APPVAGPSVFLFPPKP
VAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDP
PKDTLMISRT
EVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQ
VSHEDPEVQFN
DGVEVHNAKTKPREEQF
VHNAKTKPREEQFNSTFRVVSVLTVVHQDWL
STFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTI
SVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKT
LTVVHQDWLNGKEYKCKVSNK
DWLNGKEYKC
KCKVSNKG
GLPAPIEKTISKTKGQPREPQ
KGQPREPQVY
PREPQVYTLPPSREEMTKNQVSLTCL
QVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSD
VSLTCLVKGFYPSDIAVEWESN
TCLVKGFYPSDIAVEWESNGQPENNYKTTPP
PSDIAVEW
IAVEWESNGQPENNYKTTPP
NGQPENNYKTTPPMLDSDGSFFLYSKLT
NGQPENNYKTTPPMLDSDGSFFLYSKLTVD
TTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCS
SFFLYSKLTVDKSRWQQGNV
SKLTVDKSRWQQGNVFSCSVMHEA
TVDKSRWQ
NVFSCSVMHEALHNHYTQKS
YTQKSLSLSPGK
# Generated sample - 9921H|abrilumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Alfalytic protease - 25%
HEDPEV
QFNWYV
KPREEQFNS
NKGLPA
KGQPREPQV
KGFYPS
NGQPENNYKT
RWQQGNV
LHNHYT
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 25%
ASQGISSWLAWYQQKPGK
SGTASVVCLLNNFYPR
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 25%
TQSPSSVSASVGDRVTITCRASQGISSW
GQGTKVEIKRTVAAPSVF
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 25%
RTVAAPSVFIFPPSDEQLK
SFNRGEC
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 25%
DIQMTQSPSSVSASVG
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWY
VSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLL
GDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGA
RVTITCRASQGISS
TITCRASQG
RASQGISSWLAWYQQKPGKAPKLLIYGASNLES
SQGISSWLAWYQQKPG
SQGISSWLAWYQQKPGKAPKLLIYGASNLESGVP
GISSWLAWY
WYQQKPGKAPKLLIYGASNLESGV
GSGSGTDFTLTISSLQPEDFANY
SGTDFTLTISSLQ
SGTDFTLTISSLQPEDFANY
TLTISSLQPEDFANYYCQQANSFP
QPEDFANYYCQQANSFPW
EDFANYYCQQANSFP
ANSFPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSG
NSFPWTFGQ
QGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVV
GTKVEIKRTVAAPSVFIFPPSDEQLKSGTA
RTVAAPSVFIFPPSDEQLKSGTAS
QLKSGTASVVCLLNNFYPREAKVQWKVDNALQSG
VVCLLNNFYPREAKVQWK
LLNNFYPREAKVQWKV
LNNFYPREAKVQWKVDNALQSGNSQE
REAKVQWKVD
EAKVQWKVDNALQSG
QWKVDNALQSGNSQESVTEQDSKDS
WKVDNALQSGNSQESVTEQDS
WKVDNALQSGNSQESVTEQDSKDSTYS
NALQSGNSQESVTEQDSKDSTYSL
GNSQESVTEQD
GNSQESVTEQDSKDSTYSLSSTLTLSKADYE
ESVTEQDSKDSTYSLSSTLT
ESVTEQDSKDSTYSLSSTLTLSKADY
SVTEQDSKDSTYSLSST
KDSTYSLSSTLTLSKADYEKHKVYAC
SKADYEKHKV
# Generated sample - 9921L|abrilumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 25%
LQPEDFA
NYYCQQA
FIFPPS
DEQLKS
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Trypsin - 25%
VTISVDTSK
NQFSLK
GLPAPIEK
GFYPSDIAVEWESNGQPENNYK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Chymotrypsin - 25%
VKPSQTL
TCTVSGGSISSGEY
APCSRSTSESTAAL
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - LysC - 25%
PSQTLSLTCTVSGGSISSGEYYWNWIRQHPGK
CCVECPPCPAPPVAGPSVFLFPPK
GLPAPIEK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Aspecific - 25%
ESGPGLVKPSQTLSLTCTVSGGSISSGEYYWN
LVKPSQTLSLTCTVSGGSISSGEYYWNWIRQHPGKGLEW
KPSQTLSLTCTVS
KPSQTLSLTCTVSGGSISSGEYYWNWIRQ
CTVSGGSI
GGSISSGEYYWNWIRQHPGKGLEWIGYIYYSGSTYYNPS
SSGEYYWNWIRQHPGKGLEWIGYIYY
SGEYYWNWIRQHPGKGLEWI
RQHPGKGLEWIGYIYYSGSTYYNPSLK
GKGLEWIGYIYYSGSTYY
WIGYIYYSGSTYYNPSLKS
WIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVT
IGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTA
YSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAAD
KSRVTIS
DYWGQGT
YWGQGTLVTVSSASTKG
LVTVSSASTKGPSVFPLAPCSRSTSE
LVTVSSASTKGPSVFPLAPCSRSTSES
ALGCLVKDYFPEPVTVSWNSGALTS
LVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLS
TVSWNSGALTSGVHTFPAVLQSSG
SGALTSGVHTFPAVLQSSGLYSLSSVVTVP
AVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTK
VLQSSGLYSLSSVVTVPSSNFGTQTYTCNV
NFGTQTYTCN
NFGTQTYTCNVDHKPSNTKVDK
TQTYTCNVDHKPSNTKVDKTVERKCC
VDHKPSNTKVDK
TKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPK
VDKTVERKCCVECPPCPAPPVAGPS
VDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPK
DKTVERKCCVECPPCPAPPVAGPSVFLFP
RKCCVECPPCPAPPVA
CVECPPCPAPPVAGPSVF
PAPPVAGPSVFLFPPKPKDTLMISRTPEV
SRTPEVTCVVVDVSHEDPEVQFNWYVDGVE
TCVVVDVSHEDPEVQFN
VVDVSHEDPEVQF
VVDVSHEDPEVQFNWYVDGVEVHNAKTKPR
AKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNK
KTKPREE
STFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEK
KEYKCKVSNKGLPAPIEK
CKVSNKGLPAPIEKTISK
SKTKGQP
TKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPS
EPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVE
MTKNQVSLTCLVKGFYPSDIAVEWESNG
KNQVSLTCLVKGFYPSDIAVEW
LVKGFYPSDIAVEWESNGQPENN
YPSDIAVEWESNGQPENNYKT
ESNGQPENNYK
PENNYKTTPPMLDSDGS
NYKTTPPM
SDGSFFLYSKLTVDKSRWQQGN
SFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHY
SRWQQGN
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Alfalytic protease - 25%
GFDYWGQGT
ERKCCV
FLFPPKPKDT
PPMLDS
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Trypsin - 25%
EIVLTQSPGTLSLSPGER
FSGSGSGTDFTLTISR
SGTASVVCLLNNFYPR
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Chymotrypsin - 25%
TQSPGTL
SPGERATL
SCRASQSVSSSY
GSSPITF
PPSDEQL
KSGTASVVCL
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - LysC - 25%
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Aspecific - 25%
LSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLL
CRASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRAT
ASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGI
QSVSSSYLAWYQQKPGQAPRLLIYGTSS
WYQQKPGQAPRL
IYGTSSRATGIPDRFSGSGSGTDFTLTISRLEP
TSSRATGIP
PDRFSGSGSGTDFTLTISRLE
SGSGSGTDFTLTISRLEPED
SGSGTDFTLTISRLEPEDFAVYYCQQ
SGSGTDFTLTISRLEPEDFAVYYCQQYGSSPITFGQGT
EPEDFAVYYCQQYGSSPITF
DFAVYYCQQYGSS
DFAVYYCQQYGSSPITFGQGTRLEIKRT
ITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGT
LEIKRTVAA
PSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWK
TASVVCLLNN
LNNFYPREAKVQWKVDNALQS
REAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
EAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
VDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYE
DNALQSGNSQESV
GNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKV
NSQESVTEQDSKDSTYSLSSTLTLS
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACE
SVTEQDSKDSTYSLSSTLTLSKADYEKHK
DSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
KDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLS
DSTYSLSSTLTLSKADYEKHKVYACE
SSTLTLSKADYEKHK
HKVYACEVTHQGLSSPVTKSFNRGE
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Alfalytic protease - 25%
RLEPEDFA
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Trypsin - 25%
QVQLVESGGGVVQPGR
EEQFNSTFR
VVSVLTVVHQDWLNGK
NQVSLTCLVK
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Chymotrypsin - 25%
ADSVKGRF
CARDRGY
SSVVTVPSSNF
TCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVF
PPSREEM
ESNGQPENNY
QQGNVF
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - LysC - 25%
CCVECPPCPAPPVAGPSVFLFPPK
GLPAPIEK
NQVSLTCLVK
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Aspecific - 25%
CAASGFTFSSYGMHWVRQAPGKGLEWVAV
FSSYGMHWVR
QAPGKGLEWVAVIWYDGSNEYYADSVK
GKGLEWVAVIWYDGSNEY
LEWVAVIWYDGSNEYYAD
LEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLY
WVAVIWYDGSNEYYADSVKGRFTISRDNSK
VAVIWYDGSNEYYADSVKGRFTIS
GSNEYYADS
GSNEYYADSVK
ADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYY
SVKGRFTISRDNSKNTL
VKGRFTISRDNS
KGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRG
DNSKNTLYL
CARDRGYTSSWYPDAFDIWGQGTMVTV
GYTSSWYPDAFDIWGQGTMVTVSSASTKGPS
FDIWGQGTMVTVSSASTKGPSVFPLAPCSRST
FDIWGQGTMVTVSSASTKGPSVFPLAPCSRSTSEST
IWGQGTMVTVSSASTKG
QGTMVTVSSASTKGPSVFPLAPCSRSTSESTAALGC
PCSRSTSEST
RSTSESTAALGCLVKDYFPEPVTVSWNSGALTSG
TSESTAALGCLVKDYFPEPVTVSWNSGALTSGV
SESTAALGCLVKDYFPEPVTVSWNSGALTSGV
ESTAALGCLVKD
VKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL
NSGALTSGVHTFPAVLQSSG
GALTSGVHTFPAVLQSSGL
LTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCN
AVLQSSGLYSLSSVVTVPS
LYSLSSVVTVPSSNFGTQTYTCNVDHKPS
VVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERK
SNTKVDKTV
KTVERKCCVECPPCPAPPVAGPSVFLFPPKPK
CPPCPAPPVAGPSV
PPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVV
CPAPPVAGPSVFLFPPKPKDTL
PAPPVAGPSVFLF
PAPPVAGPSVFLFPPKPKDTLMISRTP
KPKDTLMISRTPEVTCVVVDVSHEDPEVQFN
ISRTPEVTCVVV
SRTPEVT
TPEVTCVVVDVSHEDPE
TPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKT
PEVTCVVVDVSH
EEQFNSTFRVVSVLTVVHQDWLNGKEYKCKV
VVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPR
GKEYKCKVSNKGLPAP
YKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREE
VSNKGLPAPIEKTIS
LPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQV
ISKTKGQPREPQVYT
MTKNQVSLTCLVKGFYPSD
CLVKGFYPSDI
CLVKGFYPSDIAVEWESNGQ
GFYPSDIAVEWES
GQPENNYKTTPPML
QPENNYKTTPPM
QPENNYKTTPPMLDSD
PENNYKTTPP
MLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHN
SFFLYSKLTVDKSRW
VDKSRWQQGNVFSCSVMHEAL
WQQGNVF
# Generated sample - 10425H|brazikumab|Homo sapiens||H-GAMMA-2 (VH (1-124) [D1] + CH1 (125-222) [D2] + CH2 (235-343) [D3] + CH3 (344-448) [D4])|||||||450|450|||MW undefined|MW undefined| - Alfalytic protease - 25%
YGMHWV
PGKGLEWV
RDRGYT
FDIWGQGT
KPREEQFNS
HQDWLNGKEYKCKV
NKGLPA
PPMLDS
RWQQGNV
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Trypsin - 25%
ADSSPVK
TVAPTECS
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Chymotrypsin - 25%
TQPPSVSGAPGQRVTISCTGSSSNTGAGY
QQVPGTAPKL
SGSKSGTSASL
QANKATL
KSHRSY
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - LysC - 25%
SHRSYSCQVTHEGSTVEK
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Aspecific - 25%
QSVLTQPPSVSGAPG
LTQPPSVS
VSGAPGQRVT
SGAPGQRVTISCTG
CTGSSSNTG
AGYDVHWYQQVPGTAPK
YDVHWYQQVPGTAPKLLIYG
HWYQQVPGT
PSGVPDRFSGSKSGTSA
SGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYD
SKSGTSASLAITGLQAEDEADY
KSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGG
SGTSASLAITG
SASLAITGLQAEDEADYYCQSYD
GLQAEDEADYYCQSYDSSLS
GLQAEDEADYYCQSYDSSLSGWVFGGG
LQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL
YYCQSYDSSLSGWV
SLSGWVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANK
WVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLV
PKAAPSVTLFPPSSEELQA
QANKATLVCLISDFYPGAVT
KATLVCLISDFYPGA
ATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQ
TLVCLISDFYPGAVTVAWKADSSP
SDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASS
TTPSKQSNNKY
NKYAASSYLSLTPEQWKSHRSYSCQVTHE
AASSYLSLTPEQWKS
EQWKSHRSYSCQVTHEGST
YSCQVTHEGS
SCQVTHEGS
GSTVEKTVAPT
# Generated sample - 10425L|brazikumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-111) [D1] + C-LAMBDA (112-217) [D2])|||||||217|217|||MW undefined|MW undefined| - Alfalytic protease - 25%
HWYQQV
DYYCQS
LGQPKA
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Trypsin - 25%
YYGMAVWGQGTTVTVSSASTK
TPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAK
SLSLSPGK
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Chymotrypsin - 25%
SCAASGF
VRQAPGKGL
GQGTTVTVSSASTKGPSVF
PEPVTVSW
SSVVTVPSSNF
ISRTPEVTCVVVDVSHEDPEVQF
VDGVEVHNAKTKPREEQF
PAPIEKTISKTKGQPREPQVY
PSDIAVEW
KTTPPM
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - LysC - 25%
GLEWVAVISFDGSIK
YSVDSVK
PREEQFNSTFRVVSVLTVVHQDWLNGK
GLPAPIEK
GQPREPQVYTLPPSREEMTK
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Aspecific - 25%
GVVQPGRSLRLSCAASGFTFSSFGMHWVRQAP
GRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWV
CAASGFTFSSFGMHWVRQAP
SFGMHWVRQAPGKGLEWVA
APGKGLEWVAVISFDGSIKYSVDSVKG
APGKGLEWVAVISFDGSIKYSVDSVKGRF
VAVISFD
DGSIKYSVDSV
SIKYSVDSVKGRFTISRDNSKNTLFLQMNSL
KYSVDSVKGRFTI
KGRFTISRDNSKNTLFLQMNSLRAEDTAV
NSKNTLFLQMNSLRAEDTA
NSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYK
SKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKY
TLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHY
LQMNSLRAEDTAVYYCARDR
TAVYYCARDRLNYY
DRLNYYDSSG
RLNYYDSSGYYHYKYYGMAVWGQGTTVTVSSASTKGPSVF
YYGMAVWGQGTTVTVSSASTKGPS
VWGQGTTVTVSSASTKGP
GTTVTVSSA
GTTVTVSSAST
VTVSSASTKGPSVFPLAPCSR
KGPSVFPLAPC
KGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSW
SVFPLAPCSRSTSESTAALGCLVKDYF
VFPLAPCSRSTSESTA
STSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAV
TSESTAALGCLVKDYFPEPV
SESTAAL
ESTAALG
ESTAALGCLVKDYFPEPVTVSW
TAALGCLVKDYFPEPVTVSWNSGALTSGV
PEPVTVSWNSGALTSG
VTVSWNSGALTSGVHTFPAVLQSSGLYS
SGALTSGVHTFPAVLQSSGLYSLSSVVTVPSS
SGVHTFPAVLQSSGLYSLSSVV
SLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVD
NVDHKPS
NVDHKPSNTKVDKTVERKCCV
PSNTKVDKTVERKCCV
VDKTVERKCCVECPPCPA
KTVERKCC
VERKCCVECPPCPAPPVAGPSVFLFPPKPK
RKCCVECPPCPAPPVAGPSVFLF
CCVECPPCPAPPVAGPSVFLFPPK
APPVAGPSVFLFPPKPKDTLMISRTPEV
PKPKDTLMISRTPEV
ISRTPEVTCVVVDVSHEDPEVQFNWY
ISRTPEVTCVVVDVSHEDPEVQFNWYVDGVE
PEVTCVVVDVSHEDPEVQFNWYVDG
VTCVVVDVSHEDPEVQFNWYVDGVEVHNAK
VVVDVSHEDPEV
VVVDVSHEDPEVQFNWYVDGVE
RVVSVLTVVHQDW
VVHQDWLNG
EYKCKVSNKGLPAPIEKTI
APIEKTISKTKGQPREPQVYTLPPSREEMTKNQVS
VYTLPPSREEMTKNQ
EMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTT
QVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSD
FYPSDIAVE
SDGSFFLYSKLTV
SFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLS
FLYSKLTVDKSRWQQGNV
LTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSL
VFSCSVMHEALHNHYTQKS
ALHNHYT
ALHNHYTQ
# Generated sample - 10296H|erenumab|Homo sapiens||H-GAMMA-2 (VH (1-128) [D1] + CH1 (131-228) [D2] + CH2 (241-349) [D3] + CH3 (350-454) [D4])|||||||456|456|||MW undefined|MW undefined| - Alfalytic protease - 25%
FGMHWV
LFLQMNS
GYYHYKYYGMA
KDYFPEPV
FLFPPKPKDT
NGQPENNYKT
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Trypsin - 25%
QSVLTQPPSVSAAPGQK
VTISCSGSSSNIGNNYVSWYQQLPGTAPK
LLIYDNNK
ATLVCLISDFYPGAVTVAWK
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Chymotrypsin - 25%
GQPKANPTVTL
KADGSPVKAGVETTKPSKQSNNKY
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - LysC - 25%
LLIYDNNK
ANPTVTLFPPSSEELQANK
ADGSPVK
AGVETTK
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Aspecific - 25%
LTQPPSVSAAPGQKVTISCSGSSSNIGNNYVS
QPPSVSAA
SAAPGQK
SAAPGQKVTISCSGSSSNIGNNYV
APGQKVTIS
PGQKVTISCSGSSS
CSGSSSNIGNNYVSWYQQLPGTAP
EADYYCGTWDSRLSAVVFGGGTKLTV
AVVFGGGTKLTV
LTVLGQPKANPTVTLFPPSSE
LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSP
LVCLISDFYPGAVTVAWKADGSPVKAGV
NNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVA
NKYAASSYLSLTPEQWKSHRSYSCQVTHEG
KYAASSYLSLTPEQWKSHRSYSCQVTH
SYLSLTPEQWK
SYLSLTPEQWKSHRSYSCQV
EQWKSHRS
EQWKSHRSYSCQVTHEGSTVEKTVAPT
THEGSTVEKTVA
# Generated sample - 10296L|erenumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-110) [D1] + C-LAMBDA (111-216) [D2])|||||||216|216|||MW undefined|MW undefined| - Alfalytic protease - 25%
NIGNNYV
DYYCGT
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Trypsin - 25%
EVQLVESGGGLVQPGGSLR
LSCAASGFTFSNYWMSWVR
GLEWVATIK
NYVDSVK
AEDTAVYYCATELFDLWGR
GPSVFPLAPCSR
STSESTAALGCLVK
TTPPVLDSDGSFFLYSR
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Chymotrypsin - 25%
VATIKQDGSQKNY
GPPCPSCPAPEF
GGPSVF
ESNGQPENNY
QEGNVF
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - LysC - 25%
NYVDSVK
GRFTISRDNAK
GPSVFPLAPCSRSTSESTAALGCLVK
YGPPCPSCPAPEFLGGPSVFLFPPK
SRWQEGNVFSCSVMHEALHNHYTQK
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Aspecific - 25%
GGGLVQPGGSLRLSCAAS
GGLVQPGGSLRLSCAASGFTFSNYWMSW
GLVQPGGSLRLSCAASGFTFSNYWMSW
LVQPGGS
GFTFSNYWMSWV
GFTFSNYWMSWVRQAPGKGLEWVATI
APGKGLEWVATIKQDGSQKNYVDSVKGRF
PGKGLEWVATIKQD
GSQKNYVDSV
KGRFTISRDNAKNSLYLRLNSLRAE
LYLRLNSLRAEDTAVYYC
RLNSLRAEDTAVYYCATELFDLWGRGSLVTVSSASTKGPS
NSLRAEDTAVYYCATELFDLWGRGSL
VYYCATELFDLWGRGSLVTVSSASTKGPSVF
VTVSSAS
PSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWN
LAPCSRSTSESTAALGCLV
SESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ
FPEPVTVSWNSGALTSGVHTFP
SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGT
SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTC
GVHTFPAVLQSSG
AVLQSSGLYSLSSVVTVPSSSL
SSGLYSLSSVVT
TVPSSSLGTKTY
YTCNVDHKPSNTKVDKRVE
PSNTKVDKRVESKYGPPCPSCPAPE
KVDKRVE
LFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVD
FPPKPKDTLMISRT
KPKDTLMISRTPEVTCVVVDV
PKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVH
DGVEVHNAKTKPREEQFNSTYR
HNAKTKPREEQFNSTYRVVSVL
NAKTKPREEQFNSTYR
STYRVVSVLTVLH
RVVSVLT
RVVSVLTVLHQDWLN
VLTVLHQDWLN
TVLHQDWLNGKEYKCKVSNKGLPSSIEKTIS
WLNGKEYKCKVSNKGLPSSIEK
KEYKCKVSNKGLP
YKCKVSNKGLPSSIEKTISKAKGQPRE
SIEKTISKAKGQPREPQVYTLPPSQE
EKTISKAKGQPREPQVYTLPPSQEEMTK
AKGQPREPQV
AKGQPREPQVYTLPPSQE
PQVYTLPPSQEEMTKNQVSLTCLVKGFYPS
LPPSQEEMTKNQVSLTCLVKGFYPSDIAVEW
LVKGFYPSDIAVEW
PSDIAVEWESNGQPE
VEWESNGQPENNY
VEWESNGQPENNYKTTP
EWESNGQPENNYKTTPPVLDS
ESNGQPENNYKTTPPVLDSDGSFFLYS
SNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQ
GQPENNYKTTP
GQPENNYKTTPPVLDSDG
NYKTTPPVLDSDGSFFLYSRLTV
NYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGN
KTTPPVLDSDGSFFLYSRLTVDKSRWQEGN
SFFLYSRLTVDKSRWQEGNVF
SFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKS
FFLYSRLTVDKSRWQEGNVFSCSVMHEAL
FFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKS
WQEGNVFSCSVMHEALHNHYTQK
QEGNVFSCSVMHEAL
EGNVFSCSVMHEALHNHYTQKSLSLSL
# Generated sample - 9336H|atinumab|Homo sapiens||H-GAMMA-4 (VH (1-114) [D1] + CH1 (115-212) [D2] + CH2 (225-334) [D3] + CH3 (335-439) [D4])|||||||441|441|||MW undefined|MW undefined| - Alfalytic protease - 25%
PGKGLEWV
KYGPPCPS
KPREEQFNS
KGFYPS
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 25%
SGTASVVCLLNNFYPR
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 25%
SGSGSGTDF
PREAKVQW
EKHKVY
SSPVTKSF
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 25%
SGTASVVCLLNNFYPREAK
DSTYSLSSTLTLSK
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 25%
EIVLTQSPATLSLSPGERA
ATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQA
TLSLSPGERATLSCRASQSVSSYLAW
LSPGERATLS
LSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIY
PGERATLSCRASQSVSSYLAWYQQ
GERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRA
RASQSVSSYLAW
VSSYLAWYQQKPGQAPR
YQQKPGQAPRLLIYDA
QKPGQAPRLLIYDASNRATGIP
NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQ
IPARFSGSGSGTDFTLTISSLEPED
PARFSGSGSGTDFTLTISS
ARFSGSGSGTDFTLTISSLEPEDFAVYY
FSGSGSGTDFTLTISSLEPEDFAVY
SGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITF
GSGTDFTLTISSLEPEDFAVYYCQQ
FTLTISSLEPEDFAVYY
YCQQRSNWPITFGQGTKLEIKRTVAAPSVFIFPPS
FGQGTKLEIKRTVA
FGQGTKLEIKRTVAAPS
GTKLEIKRTVA
EIKRTVAAPSVFIFPPSDEQLKSGT
PSVFIFPPSDEQLKSGTASVVCLLNNFY
DEQLKSGTASVV
DEQLKSGTASVVCL
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQ
QLKSGTASVVCLLNNFYPREAKVQWKVDNALQSG
SGTASVVCLLNNFYPREAKVQWK
ASVVCLLNNFYPREAKVQWKV
SVVCLLNNFYP
FYPREAKVQWKVDNALQS
PREAKVQWKVDNAL
PREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLS
EAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
EQDSKDSTYSLSSTLTLSKADYEKHKVYACE
DSTYSLSSTLTLSKADYEKHKVYAC
YSLSSTLTLSKADYEKHKVY
HKVYACEVTHQGLSSPVTK
# Generated sample - 9336L|atinumab|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 25%
PRLLIYDA
YYCQQRS
FIFPPS
DEQLKS
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Trypsin - 25%
GLEWIGSIYK
VTISVDTSK
LSSVTAADTAVYYCTRPVVR
GPSVFPLAPCSR
YGPPCPPCPAPEFEGGPSVFLFPPKPK
NQVSLTCLVK
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Chymotrypsin - 25%
QESGPGL
CTRPVVRY
SSVVTVPSSSL
GPPCPPCPAPEF
ISRTPEVTCVVVDVSQEDPEVQF
VDGVEVHNAKTKPREEQF
TKNQVSL
PSDIAVEW
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - LysC - 25%
SRVTISVDTSK
GPSVFPLAPCSRSTSESTAALGCLVK
NQVSLTCLVK
SRWQEGNVFSCSVMHEALHNHYTQK
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Aspecific - 25%
ESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQP
ESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPP
GPGLLKPSETLSLTCTVSGGSISSPGY
KPSETLS
TLSLTCTVSGGSIS
SISSPGYYGGWIRQP
YYGGWIRQPPGKGLEWIGSIYK
QPPGKGLEWIGSIYKSGSTYHNPSL
LEWIGSI
EWIGSIYKS
SIYKSGSTYHNPSLKSRVTISVDTSKN
GSTYHNPSLKSRVTI
NPSLKSRVTISVDTSKNQFSL
RVTISVDTSKNQFSLKLSSVTAADTAVYYCTRP
SKNQFSLKLSSVTAADTAVYYCTRP
NQFSLKLSSVTAADTAVYYC
NQFSLKLSSVTAADTAVYYCTRPVVRYFGWF
LKLSSVTAADTAV
LSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVT
YYCTRPVVRYFGWFDPWGQGTLVTVSSASTKG
FDPWGQGTLVTVSSAS
WGQGTLVTVSSASTKGPSVFP
QGTLVTVSSASTKGPSVFPLAP
VTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFP
PLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTS
PEPVTVSWNSGALTSGVHTFPA
VTVSWNSGALTSGVHTFPAVLQSSGLY
GVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTC
TFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNV
QSSGLYSL
SSGLYSLSSVVTV
YSLSSVVTVPSSSLGTKTYTCNVDHKPS
VVTVPSSSLGTKTYTCNVDHKP
SSSLGTKTYTCNVDHKPSNTKVDKRV
SLGTKTYT
SLGTKTYTCNVDHKPSNTKVDKRVESKYGPPC
GTKTYTCNVDHKPSNTKVDKRVESKYGPPCP
TYTCNVDHK
TYTCNVDHKP
YTCNVDHKPSNTKVDKRVESKYGPPCPPC
HKPSNTK
PEFEGGPSVFLFPPKPKDTLMISRTP
PSVFLFPPKPKDTLMISRTPEVTCVVVDV
DTLMISRTPEVTCVVVDVSQ
TPEVTCVVVDVSQEDPE
QEDPEVQFNWYVDGVEVHNAKT
DPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVL
NWYVDGVEVHNAKTKPRE
VEVHNAKTKPREEQFNSTYRVVSVLTVL
KPREEQFN
VLHQDWLNGKEYKCKVS
HQDWLNGKEYKCKVSNKGL
YKCKVSNKGLPS
VSNKGLPSSIEKTISKAKGQP
ISKAKGQ
AKGQPREPQVYTLPPSQEEM
NQVSLTCLVKGFYPSDIA
GFYPSDIAV
PSDIAVEWESNGQPENNYKTTPPVLDSDG
IAVEWESNGQP
ENNYKTTPPVLDSDGSFFLYS
VLDSDGSFFLYSRLTV
SDGSFFLYSRLT
GSFFLYSRLTVDKSRWQEGNVFSCSVMHE
YSRLTVDKSRWQEGNVFSCSVMHE
WQEGNVFSCSVMHEALHNHYTQKSLSL
NVFSCSVM
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Alfalytic protease - 25%
PGYYGGWIRQPPGKGLEWIGS
QFNWYV
KPREEQFNS
LHNHYT
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Trypsin - 25%
AIQLTQSPSSLSASVGDR
LLIYDASNLESGVPSR
SGTASVVCLLNNFYPR
VDNALQSGNSQESVTEQDSK
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Chymotrypsin - 25%
SGSGSGTDF
GQGTKVEIKRTVAAPSVF
QSGNSQESVTEQDSKDSTY
ACEVTHQGL
SSPVTKSF
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - LysC - 25%
VYACEVTHQGLSSPVTK
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Aspecific - 25%
LTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGK
SPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPK
VTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGV
QGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSG
GISSALAWYQQKPGKAPK
YQQKPGKAPKLLIYDASNLESGVPSRFSG
QQKPGKAPKLLI
LESGVPS
LESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFN
SGVPSRFSGSGSGT
SGVPSRFSGSGSGTD
TLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIKR
LTISSLQPEDFA
SLQPEDFATYYCQQFNSYPTFGQGTKV
QPEDFATYYCQ
EDFATYYCQQFNSYPTFGQGTKVEIKRTVAA
CQQFNSYPTFGQGTKVEIKRTVAAPSV
TFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTA
TKVEIKRTVAAPSVFIF
KRTVAAPSVFIFPPSDEQLKSGTASVVC
TVAAPSVFIFPPSDEQLK
VFIFPPSDEQLKSGT
REAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL
VQWKVDNALQSGNSQESVTEQD
KVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKAD
ALQSGNSQE
LQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKH
LQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHK
NSQESVTEQDSKDSTYSLSSTLTLSKAD
SQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYAC
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVY
YSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
TLSKADYEKHKVYACEVTHQG
YEKHKVYACEVTHQGLS
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Alfalytic protease - 25%
WYQQKPGKA
PKLLIYDA
DEQLKS
DYEKHKV
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Trypsin - 25%
EPQVYTLPPSQEEMTK
GFYPSDIAVEWESNGQPENNYK
WQEGNVFSCSVMHEALHNHYTQK
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Chymotrypsin - 25%
TTDTSTSTAY
RSDDTAVY
PEPVTVSW
TCNVDHKPSNTKVDKRVESKY
ISRTPEVTCVVVDVSQEDPEVQF
PSSIEKTISKAKGQPREPQVY
DSDGSF
QEGNVF
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - LysC - 25%
PGASVK
TYTCNVDHK
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Aspecific - 25%
LVQSGAEVKKPGASVKVS
LVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPG
VQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVR
ASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANN
YGLSWVRQAPGQGLEWMGWISANNGDT
LSWVRQAPGQGLEWMGWISANNGDTNYG
GQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTS
GQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTA
QGLEWMGWISANNGDTNYGQEFQG
WISANNGDTNYGQEF
DTNYGQEFQGRVTMTTDTSTSTAYME
DTNYGQEFQGRVTMTTDTSTSTAYMEL
QEFQGRVTMTTDTSTSTAYMELRSLRSDDT
EFQGRVTMTTDTSTSTAYME
TAYMELRSLRSDDTAVYYCARDSSSSWARW
AYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRG
ELRSLRSDDTAVYYCA
TAVYYCARDSSSSWARWFFDLWGR
SSSSWARWFFDLWGRGTLVTVSSASTKGPSVFPLAPCSR
WFFDLWGRGTLVTVSSAS
FPLAPCSRSTSESTAALGCLVKDYFPE
LAPCSRS
APCSRSTSESTAALGCLVKDY
STSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPA
ESTAALGCLVKDYFPEPVTVSWNSGA
AALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
LVKDYFPEPVTVSWNSGA
SGALTSGVHTFPAVLQSSGLYSL
GALTSGVHTFPAVLQSSGLY
LTSGVHTFPAVLQSSGLYSLSSVVTVP
GVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTC
VHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKP
FPAVLQS
VLQSSGLYSLSSVVTVPSSSLGTKTYTC
LYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKV
YSLSSVVTV
VPSSSLGTKTYTCNVDHK
SSSLGTKTYTCNVDHKPSNTKVDK
SSSLGTKTYTCNVDHKPSNTKVDKRVESKYG
NTKVDKRVESKYGPPCPSCPAPEFLGGPSVFLFPPKP
TKVDKRVESKY
PEFLGGPSVFLFPPKPKDTLMIS
PEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQED
PSVFLFPPKPKDTLM
KDTLMISRTPEVTCVVVDV
SRTPEVTCVVVDVSQEDPEVQFNWYVDG
PEVTCVVVDVSQED
VDVSQEDPEVQF
VQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTV
QFNWYVDGVEVHNAKTKPREEQFNST
NWYVDGVEVHNAKTKPREEQFNSTYRV
YVDGVEVHNAKTKPREEQFNSTYRVVSVLTV
VHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNG
HNAKTKPREEQFNSTYRVVSVLTV
KPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCK
TYRVVSVLTVLHQDWLNGKEYK
RVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEK
TVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREP
LHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREP
SIEKTISKAKGQPREPQVYTLPPSQEEM
GQPREPQVYTLPPSQEEM
PREPQVYTLPPSQEE
LPPSQEEMTKNQVSLTC
PPSQEEMTKNQVSLTCLVKGFYP
EMTKNQVSLTCLVKG
TKNQVSLTCLVKGFYPSDIAVEWE
PSDIAVEWESNGQP
DIAVEWESNGQPENNYKTTPP
IAVEWESNGQPENNYKTTP
IAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDK
IAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSR
WESNGQPENNYKTTPPVLDSDGS
QPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSC
TPPVLDSDGSFFLYSRL
DGSFFLYSRLTVDKSR
VDKSRWQEGNVFSCSVMHEALHNHYT
GNVFSCSVMHEALHN
VMHEALHNHYTQKSLSLSLG
# Generated sample - 9235H|tralokinumab|Homo sapiens||H-GAMMA-4 (VH (1-122) [D1] + CH1 (123-220) [D2] + CH2 (233-342) [D3] + CH3 (343-447) [D4])|||||||449|449|||MW undefined|MW undefined| - Alfalytic protease - 25%
KDYFPEPV
NKGLPS
KGFYPS
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 25%
YAASSYLSLTPEQWK
SYSCQVTHEGSTVEK
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 25%
KSHRSY
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 25%
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 25%
IGSKLVHWYQQKP
SKLVHWYQQKPGQAPVLVIY
KLVHWYQQKPGQAPVLVIYDDGDRPSG
YQQKPGQAPVLVIYDDGDRPSGIP
QAPVLVIYDDGDRPSGIPERFSGSN
DGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADY
FSGSNSGNTATLTISRVEAGDEADYY
TISRVEAGDEADYYCQVWDTGSDPVVFGG
EADYYCQVWDTGSDPVVFGGGTKLTVLGQP
CQVWDTGSDPVVFGGGTKLTVL
DTGSDPVVFGG
DPVVFGGGTKLTVLGQPKAAPSVT
KAAPSVTLFPPSSEE
APSVTLFPPSSEELQANKATLVCLISDFY
TLFPPSSEELQANKATLVCLISDFYPGAVTV
PSSEELQANKATLVCLISDFYP
EELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGV
PGAVTVAWKADSSPVKAGVETTTPS
GAVTVAWKADSSPVKAGVETTTPSKQSNNKYAAS
SPVKAGVETT
QSNNKYAASSYLSLTPEQWKSHRSYSCQVTHE
SSYLSLTPEQWKSHRSYSCQVTHEGSTV
SYLSLTP
SYLSLTPEQWKSHRSYSCQVTHEGSTVEK
QWKSHRSYS
# Generated sample - 9235L|tralokinumab|Homo sapiens||L-LAMBDA (V-LAMBDA (1-108) [D1] + C-LAMBDA (109-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 25%
GIPERFS
